Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular E...(uld cause actual results developments an...),Health

Date:11/5/2009

uld cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements may be found in our most recent Annual Report on Form 20-F, including the section therein entitled “Risk Factors”, as well in our reports on Form 6-K, filed with the Securities and Exchange Commission.

# # #

Read the full story at http://www.prweb.com/releases/2009/11/prweb3166174.htm.

'/>"/>

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
3. Alma Lasers Answers Lumenis Complaint
4. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
5. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
6. Lumenis Announces changes in Lumenis Vision Strategic Business Unit
7. Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting
8. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
9. Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
10. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure
11. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure